USPTO serial 86655036
SYNTHON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- AYALA, LOURDES
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SYNTHON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATIONS, SUBSTANCES AND COMPOSITIONS FOR THE TREATMENT OF CANCER, MULTIPLE SCLEROSIS AND OTHER DISORDERS IN THE CENTRAL NERVOUS SYSTEM, NEOPLASMS AND AUTOIMMUNE DISEASES AS WELL AS OTHER DISEASES; BIOLOGICAL AND BIOCHEMICAL DRUG AND CULTURES FOR MEDICAL USE, NAMELY, BIOLOGICAL TISSUE CULTURES FOR MEDICAL PURPOSES; CULTURE FLUIDS FOR CULTIVATING HUMAN, AND ANIMAL CELLS AND PLANTS, PLANT CELLS OR PLANT TISSUES; CULTURE MEDIA FOR CULTIVATING HUMAN, AND ANIMAL CELLS AND PLANTS, PLANT CELLS OR PLANT TISSUES; MEDIA FOR USE IN CULTURING EUKARYOTIC CELLS; PHARMACEUTICAL BIOLOGICAL AND BIOCHEMICAL DRUGS FOR THE TREATMENT OF NEOPLASMS AND AUTOIMMUNE DISEASES | ACTIVE | — |
| 010 | SURGICAL DEVICES AND INSTRUMENTS; INJECTION APPARATUS FOR MEDICAL PURPOSES, NAMELY, INJECTORS AND SYRINGES FOR MEDICAL PURPOSES AND FOR INJECTIONS | ACTIVE | — |
| 035 | OFFICE FUNCTIONS RELATING TO THE REGISTRATION OF PHARMACEUTICAL PREPARATIONS AND COMPONENTS AND PHARMACEUTICAL DRUGS; OFFICE FUNCTIONS RELATING TO OBTAINING PHARMACEUTICAL REGISTRATIONS AND COMPILING PHARMACEUTICAL REGISTRATION FILES; BUSINESS MEDIATION OF AGREEMENTS REGARDING THE PURCHASE, SALE AND LICENSING OF PHARMACEUTICAL REGISTRATIONS AND PHARMACEUTICAL REGISTRATION DOSSIERS; BUSINESS ADVICE AND INFORMATION; BUSINESS CONSULTATION; PROCUREMENT OF CONTRACTS FOR OTHERS FOR THE PURCHASE AND SALE OF GOODS; BUSINESS SERVICES, NAMELY, COMPILING OF PHARMACEUTICAL REGISTRATION DOSSIERS FOR OTHERS | ACTIVE | — |
| 040 | TREATMENT OF MATERIALS FOR THE MANUFACTURE OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS; MANUFACTURE, FOR OTHERS, OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS AND RAW MATERIALS FOR THE PHARMACEUTICAL INDUSTRY | ACTIVE | — |
| 042 | SCIENTIFIC LABORATORY SERVICES; SCIENTIFIC RESEARCH AND DEVELOPMENT; SCIENTIFIC AND TECHNOLOGICAL SERVICES, NAMELY, SCIENTIFIC ANALYSIS AND TESTING SERVICES IN THE FIELD OF PHARMACEUTICALS AND PHARMACEUTICAL INGREDIENTS; SCIENTIFIC CONSULTATION SERVICES IN THE FIELD OF PHARMACEUTICALS AND PHARMACEUTICAL INGREDIENTS; SCIENTIFIC INVESTIGATIONS FOR MEDICAL PURPOSES; PHARMACEUTICAL RESEARCH AND DEVELOPMENT; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES; LABORATORY RESEARCH SERVICES RELATING TO PHARMACEUTICALS; CONSULTING SERVICES IN THE FIELDS OF BIOTECHNOLOGY AND PHARMACEUTICAL RESEARCH AND DEVELOPMENT; BIOMEDICAL RESEARCH AND CONSULTANCY; MEDICAL RESEARCH; MEDICAL LABORATORIES; CHEMISTRY AND BIOLOGY LABORATORIES; SCIENTIFIC LABORATORY SERVICES; DEVELOPMENT OF PHARMACEUTICAL PRODUCTS AND INGREDIENTS; PROVIDING MEDICAL AND SCIENTIFIC RESEARCH INFORMATION IN THE FIELD OF PHARMACEUTICALS; PROVIDING MEDICAL AND SCIENTIFIC RESEARCH INFORMATION IN THE FIELD OF CLINICAL TRIALS; QUALITY MANAGEMENT SERVICES, NAMELY, QUALITY EVALUATION AND ANALYSIS, QUALITY ASSURANCE AND QUALITY CONTROL, IN THE FIELD OF PHARMACEUTICALS; LABORATORY RESEARCH AND LABORATORY ANALYSIS SERVICES RELATING TO PHARMACEUTICALS AND PHARMACEUTICAL INGREDIENTS; RESEARCH AND SCIENTIFIC DESIGN OF PHARMACEUTICAL PRODUCTS AND INGREDIENTS FOR THE PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT IN THE FIELD OF ONCOLOGY, CENTRAL NERVOUS SYSTEM, NEOPLASMS AND AUTOIMMUNE DISEASES AND LIFE-THREATENING DISEASES; DRUG DISCOVERY; PRODUCT QUALITY TESTING; CONDUCTING CLINICAL TRIALS FOR PHARMACEUTICAL PREPARATIONS; CONDUCTING QUALITY CONTROL OF PHARMACEUTICAL PREPARATIONS; PROVIDING INFORMATION AND DATA RELATING TO PHARMACEUTICAL RESEARCH AND DEVELOPMENTS, BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENTS AND MEDICAL RESEARCH AND DEVELOPMENTS | ACTIVE | — |
| 045 | LEGAL SERVICES RELATING TO OBTAINING PHARMACEUTICAL REGISTRATIONS AND COMPILING PHARMACEUTICAL REGISTRATION FILES; LEGAL SERVICES, NAMELY, MANAGEMENT OF INTELLECTUAL PROPERTY, KNOW-HOW AND COPYRIGHT; LICENSING OF INTELLECTUAL PROPERTY AND KNOW-HOW, INCLUDING DOSSIERS FOR OBTAINING PHARMACEUTICAL REGISTRATIONS; PROVIDING LEGAL SERVICES AND INFORMATION IN THE FIELD OF INTELLECTUAL PROPERTY; LEGAL ADVICE IN THE FIELD OF INTELLECTUAL PROPERTY | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Synthon Holding B.V.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named SYNTHON
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2016 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 8, 2016 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 2, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 2, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 2, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 7, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2016 | ALIE | ASSIGNED TO LIE | — |
| Mar 21, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 21, 2015 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2015 | NWAP | NEW APPLICATION ENTERED | — |